News
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...
The U.S. Food and Drug Administration and the pharmaceutical company Novo Nordisk are urging consumers to be on the lookout ...
The stock fell after Eli Lilly announced results of a new pill that could rival the weight-loss potential of the Danish giant ...
In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, ...
Novo Nordisk's stocks face YTD struggles due to trial results and tariffs, but strong fundamentals and outlook justify a Buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results